Usana Health Sciences
USNA
172 hedge funds and large institutions have $573M invested in Usana Health Sciences in 2022 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 58 increasing their positions, 76 reducing their positions, and 26 closing their positions.
1.22% less ownership
Funds ownership: 54.48% → 53.26% (-1.2%)
5% less funds holding
Funds holding: 182 → 172 (-10)
24% less repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 76
24% less capital invested
Capital invested by funds: $758M → $573M (-$185M)
35% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 26
44% less call options, than puts
Call options by funds: $22K | Put options by funds: $39K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$1.97M |
| 2 |
Man Group
London,
United Kingdom
|
+$1.87M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$1.21M |
| 4 |
DA
Denali Advisors
San Diego,
California
|
+$1.16M |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$926K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$8.2M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$3.1M |
| 3 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
-$1.86M |
| 4 |
WG
Winton Group
London,
United Kingdom
|
-$1.55M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.54M |
USNA Hedge Fund Activity: Q3 2022 in Review
172 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q3 2022, worth a combined $573M — down 24% from $758M a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of USNA and 17 opened new positions — a net loss of 9 holders — while 76 trimmed existing stakes and 58 added.
The largest buyer was UBS Group, adding an estimated $1.97M. The largest seller was Renaissance Technologies, cutting an estimated $8.2M.
- 172 institutional investors held Usana Health Sciences (USNA) as of Q3 2022, down from 182 in Q2 2022.
- Funds reported $573M of Usana Health Sciences stock for Q3 2022, down 24% quarter-over-quarter.
- 17 funds opened new Usana Health Sciences positions in Q3 2022 and 26 closed out, a net change of -9 holders.
- The largest Usana Health Sciences buyer in Q3 2022 was UBS Group, an estimated $1.97M added.
- The largest Usana Health Sciences seller in Q3 2022 was Renaissance Technologies, an estimated $8.2M sold.
Based on aggregated 13F filings for Q3 2022.